Sweden's Paxman Q1 revenue rises 34% on Dignitana acquisition

Paxman AB (publ)

21/05/2026 06:09

Overview

Sweden scalp cooling tech supplier's Q1 revenue rose 34% yr/yr, driven by Dignitana acquisition

Q1 EBITDA increased, supported by positive contribution from Dignitana

Net loss narrowed in Q1, impacted by acquisition-related goodwill amortisation costs

Outlook

Company highlights new CPT codes effective Jan 2027 for cryocompression therapy in the U.S.

Company notes scalp cooling insurance mandates in West Virginia and Maryland effective Jan 2027

Company says expanded reimbursement access in U.S. from new CPT codes effective Jan 2026

Result Drivers

DIGNITANA ACQUISITION - Dignitana contributed 18.9 mln SEK to Q1 sales and 5.8 mln SEK to EBITDA

ACQUISITION COSTS - Net result impacted by 5.3 mln SEK in acquisition-related goodwill amortisation costs

OPERATING RECEIVABLES - Decline in operating cash flow attributed to increased operating receivables

Company press release: ID:nMFN18KwDT

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
SEK 89.60 mln
SEK 88.50 mln (2 Analysts)
Q1 EPS
-SEK 0.01
Q1 Net Income
-SEK 100,000
Q1 EBITDA
SEK 10.50 mln
SEK 8.50 mln (2 Analysts)
Q1 Operating Cash Flow
-SEK 2.20 mln


Analyst Coverage

Wall Street's median 12-month price target for Paxman AB (publ) is SEK98.00, about 96.2% above its May 20 closing price of SEK49.95

The stock recently traded at 18 times the next 12-month earnings vs. a P/E of 25 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)